A widely used breast cancer drug could give IVF a boost, with new research showing that adding it to the standard hormone ...
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found ...
Most of the oncology drugs that received the FDA’s accelerated approval from 2011 to 2020 had some kind of FDA postmarketing safety action, according to a research letter. Safety actions included ...
Please provide your email address to receive an email when new articles are posted on . Most oncology drugs that received FDA accelerated approval between 2011 and 2020 required postmarketing safety ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. A common cancer drug has been restructured to make its cancer cell killing abilities up to 20,000 times more effective ...
Commonly prescribed cardiovascular medications - such as statins, diuretics, and blood pressure drugs - appear to have little or no negative impact on survival among people living with multiple ...
Common Metabolic Enzyme Could Predict Cancer Immunotherapy Benefits — and Help More Patients Respond
A Rutgers Cancer Institute study in Cell Reports Medicine promises help with both those problems. It identifies a protein ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results